Ruben Mesa: Gene Mutations and Checkpoint Inhibitors in Head and Neck Cancer Discussed at ASCO25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, posted on LinkedIn:

“Implications of gene mutations and checkpoint inhibitors in HN Cancer. Important work by our Atrium Health Wake Forest Baptist Comprehensive Cancer Center team presented at ASCO25 by Daniel Stamos and senior colleagues.”

Ruben Mesa: Gene Mutations and Checkpoint Inhibitors in Head and Neck Cancer Discussed at ASCO25

“Implications of gene mutations and checkpoint inhibitors in HN Cancer. Important work by our Atrium Health Wake Forest Baptist Comprehensive Cancer Center team presented at ASCO25 by Daniel Stamos and senior colleagues.”